IS7596A - Hringbrædd pýrrólefnasambönd sem róteindadælutálmar til að meðhöndla magasár - Google Patents

Hringbrædd pýrrólefnasambönd sem róteindadælutálmar til að meðhöndla magasár

Info

Publication number
IS7596A
IS7596A IS7596A IS7596A IS7596A IS 7596 A IS7596 A IS 7596A IS 7596 A IS7596 A IS 7596A IS 7596 A IS7596 A IS 7596A IS 7596 A IS7596 A IS 7596A
Authority
IS
Iceland
Prior art keywords
treatment
proton pump
gastric ulcer
pump inhibitors
pyrrole compounds
Prior art date
Application number
IS7596A
Other languages
English (en)
Inventor
J. Smolka Adams
E. Hammond Charles
Gupta Sandeep
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/005171 external-priority patent/WO2003097041A1/en
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of IS7596A publication Critical patent/IS7596A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7596A 2002-05-17 2004-12-15 Hringbrædd pýrrólefnasambönd sem róteindadælutálmar til að meðhöndla magasár IS7596A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38092802P 2002-05-17 2002-05-17
EP02011081 2002-05-17
PCT/EP2003/005171 WO2003097041A1 (en) 2002-05-17 2003-05-16 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer

Publications (1)

Publication Number Publication Date
IS7596A true IS7596A (is) 2004-12-15

Family

ID=29551322

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7596A IS7596A (is) 2002-05-17 2004-12-15 Hringbrædd pýrrólefnasambönd sem róteindadælutálmar til að meðhöndla magasár

Country Status (3)

Country Link
US (1) US20060040945A1 (is)
IL (1) IL164735A0 (is)
IS (1) IS7596A (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2607953A1 (en) * 2005-05-09 2006-11-16 Tap Pharmaceutical Products, Inc. Methods for treating nephrolithiasis
EP1940397A4 (en) * 2005-08-03 2010-01-20 Takeda Pharmaceuticals North A METHOD FOR TREATING HYPERTONIA
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
EP2101761A4 (en) * 2006-11-13 2010-01-27 Takeda Pharmaceuticals North A METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS
CN101646440A (zh) * 2007-01-19 2010-02-10 武田制药北美公司 使用黄嘌呤氧化还原酶抑制剂和抗炎剂预防痛风突发或减少痛风突发次数的方法
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
AU2011299153B2 (en) 2010-09-10 2014-10-30 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat
CN113549079A (zh) 2018-05-25 2021-10-26 正大天晴药业集团股份有限公司 2,3-二氢-1h-吡咯嗪-7-甲酰胺类衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
AP2002002582A0 (en) * 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
JP2005504781A (ja) * 2001-08-30 2005-02-17 メルクル・ゲーエムベーハー 環付加したピロール化合物の関節軟骨または軟骨下骨変性の治療における使用

Also Published As

Publication number Publication date
US20060040945A1 (en) 2006-02-23
IL164735A0 (en) 2005-12-18
HK1072379A1 (en) 2005-08-26

Similar Documents

Publication Publication Date Title
IS7095A (is) Arýlamín til meðhöndlunar á ástandi sem tengist GSK-3
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
IL174075A0 (en) 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
SI2039685T1 (sl) Heterobiciklične spojine kot P38 inhibitorji
ID30176A (id) Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
EP1827366A4 (en) STABILIZED CALCIUM PHOSPHATE COMPLEXES
IL179844A0 (en) Five-membered heterocycles useful as serine protease inhibitors
AU2003293356A8 (en) Dihydropyridinone derivatives as hne inhibitors
GB0222056D0 (en) Process for the manufacture of organic compounds
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
DK1492821T3 (da) Jerndextrinforbindelser til behandling af jernmangelanæmi
ZA200709072B (en) Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
GB0204129D0 (en) Process for the manufacture of organic compounds
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
GB0403165D0 (en) Novel uses for proton pump inhibitors
IL165562A0 (en) Prodrugs of imidazole derivatives for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
AU2003239508A8 (en) Indole compounds useful as impdh inhibitors
IS7596A (is) Hringbrædd pýrrólefnasambönd sem róteindadælutálmar til að meðhöndla magasár
EE200300442A (et) Meetod imidasoolühendite valmistamiseks
GB0210234D0 (en) Process for the manufacture of organic compounds
IS7795A (is) Pyrrólafleiður sem efnasambönd gegn sveppagerlum
DE60325855D1 (de) Rifampicin zur Behandlung der Angiogenese
GB0402262D0 (en) Process for the manufacture of organic compounds
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem